TU München Researchers Identify A New Breast And Ovarian Cancer Susceptibility Gene

Technische Universitat Munchen -- The discovery 15 years ago that the genes BRCA1 and BRCA2 confer high risks for breast and ovarian cancer was a breakthrough for cancer prediction and therapy, especially for familial cases. Now, the research group of Prof. Alfons Meindl (Klinikum rechts der Isar of the Technische Universität München), in collaboration with other groups from Germany, the U.K., and the U.S., can identify another gene that increases susceptibility to breast and ovarian cancer. Their results have been published online in Nature Genetics. The identification of such high risk-conferring genes is a prerequisite for offering women tailored early recognition programs and more individualized therapies.